申请人:TAISHO PHARMACEUTICAL CO. LTD
公开号:EP1004295A1
公开(公告)日:2000-05-31
Powdery aerosol preparation improved in the adherence of the powder itself and the effective components thereof to the skin and excellent in the feeling of use, characterized by comprising 50 to 90 % by weight of a propellant having a vapor pressure at 20 °C of not higher than 4.5 kg/cm2, 5 to 30 % by weight of an aliphatic hydrocarbon having a boiling point of 5 to 40 °C, 0.5 to 20 % by weight of a powdery component, and 1 to 20 % by weight of a lower alcohol in a container provided with a straight button of an aperture of 0.7 to 2.0 mm.
粉末状气溶胶制剂,其粉末本身及其有效成分与皮肤的附着力得到改善,使用感极佳,其特征在于,按重量计,包含 50 至 90 % 的推进剂,该推进剂在 20 °C 时的蒸气压不高于 4.5 kg/cm2 的推进剂,5%至 30%(重量百分比)沸点为 5 至 40 °C 的脂肪族碳氢化合物,0.5%至 20%(重量百分比)的粉末状成分,以及 1%至 20%(重量百分比)的低级醇,装在一个带有孔径为 0.7 至 2.0 mm 的直扣的容器中。